All episodes
Welcome And Introductions
Special Panel 40 Years Later: Looking Back at the Beginning of the HIV/AIDS Epidemic in Atlanta, GA
(April 1, 2022) The Latest on Omicron Subvariant BA.2 in the US, 4th Dose, and Vaccine in Children
Antiretroviral Therapy Cases From the Clinic(ians): A Case-Based Presentation and Panel Discussion
In Case You Missed It: Updates From CROI 2022 and Beyond
(February 4, 2022) Latest Update on COVID-19 Vaccines and Scientific Leaders’ Perspectives
Welcome
Investigational Antiretroviral Drugs and Strategies
COVID-19 Interactions with Other Viruses
Current Options for Treating and Managing COVID-19
Updated CDC Guidelines on Testing and Treating Sexually Transmitted Infections
State-of-the-art Cases on Antiretroviral Therapy
In Case You Missed It: Updates From Recent Publications and Meetings
Expert Roundtable Discussion
(December 3, 2021) Omicron Variant, Therapeutics, and COVID-19 in People Who Are Immunocompromised
Welcome
PrEP: State of the Science Overview
Strategies to Optimize PrEP: Schedules, Formulations, and Innovative Approaches
Assessing and Monitoring Persons Interested in Starting and Continuing PrEP
Question-and Answer Panel Session
Ending the HIV Epidemic: The Impact of PrEP
How to Reach the Hard to Reach: Policies and Strategies to Address Access to PrEP
Leveraging Administrative and Governmental Policies to Improve PrEP Utilization
Expert Roundtable Discussion
Closing
(October 22, 2021) COVID-19 in People Who Are Immunocompromised, Waning Immunity, Breakthrough...
Assessing Frailty in Older People With HIV
Neurocognition and the Aging Brain
Cardiovascular Disease in HIV: Moving From Insights to Interventions
Identifying, Managing, and Preventing Polypharmacy in Older People With HIV
Primary Care Concerns for the Aging Population
Expert Roundtable Discussion
SARS-CoV-2 Variants: Where Did They Come From and Where Are They Going (June 18, 2021)
Up to Date on COVID-19: Expert Discussion (June 1, 2021)
Challenges and Opportunities in Providing Remote HIV, STI, and COVID-19 Testing and Services
Challenges and Opportunities for Preexposure Prophylaxis
Vaccine Prevention for Individuals With HIV in the Era of COVID-19
HIV and COVID-19: Impact on Susceptibility, Disease, and Long-term Complications
Preventing Severe COVID-19: The Role of Monoclonal Antibodies and Beyond
Panel Discussion
Update From vCROI 2021
Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion
Challenges and Opportunities for Preexposure Prophylaxis
Management and Prevention of Sexually Transmitted Infections
Immunology and Pathogenesis of COVID-19
Long COVID-19: Long-Term Complications of COVID-19
Current Antiretroviral Drugs and Strategies for HIV Management
Investigational Antiretroviral Drugs for HIV
Collateral Damage of COVID-19 onHIVPatient Care
Current Status of COVID-19 TreatmentOptions for Mild, Moderate, and Severe Disease
Aging and Frailty in People With HIV
Drug-Drug Interactions and Polypharmacyin HIV: Case-Based
HIV Stigma and Unreached Populations
Challenges and Success in PrEP Implementation
Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion
Long-Acting Antiretroviral Drug Formulations for Treatment and Preventionof HIV
Update on Early Treatment of COVID-19 (April 13, 2021)
Latest on “COVID-19 Meets HIV”: Variants, Vaccines, and Health Disparities (February 10, 2021)
Update on New Strategies for Antiretroviral Therapy
Challenges and Opportunities for Preexposure Prophylaxis
Aging and Frailty in People With HIV
Long COVID-19: The Long-Term Complications of COVID-19
Neurologic Complications of COVID-19
The Inexorable Advancement to Long-Acting Antiretrovirals: To Jupiter and Beyond!
Update on SARS-CoV-2 Variants, Vaccine Development, and Decreasing the Case Rate (January 29, 2021)
Update on COVID-19 Vaccines (January 4, 2021)
Impact of the COVID-19 on HCV and STIs (November 23, 2020)
Update From Our Nation’s Capital, ID Week, and OI Guidelines
PrEP in the Era of COVID-19: A Case-Based Discussion
Projected Health Policy Changes in 2021
Update on the Clinical Management of HIV: A Case-Based Discussion
Where We Stand Today on a SARS-CoV-2 Vaccine
Antiretroviral Therapy: When and What to Start
When and How to Switch ART Regimens
Ending the HIV Epidemic
Laboratory Monitoring in Individuals With HIV
Prevention of HIV Infection
COVID-19 Update: Including the Intersection of HIV
Aging and HIV: Polypharmacy, Frailty, and Neurocognition
Lessons From the Lab: Implications for Coronavirus Vaccine and Therapeutics (October 19, 2020)
Addressing Questions About COVID-19 (September 23, 2020)
HIV and COVID-19 Interactions and Parallels in Advocacy (September 15, 2020)
New Strategies and Challenges of PrEP in the COVID-19 Era (September 9, 2020)
Continued Discussion on COVID-19 Epidemiology and Transmission (August 19, 2020)
Investigational New Antiretroviral Drugs and Strategies
Interactive Antiretroviral Therapy Cases
COVID-19: Update on Therapy and Vaccine Research
Preexposure Prophylaxis: Cases and Common Questions
HIV and Opioid Use: The Intersection of the Co-Epidemics in the Midwest
Current Status of COVID-19 Treatment and Vaccine Research (July 31, 2020)
Insights From AIDS 2020/COVID-19 at IAS, Updates on COVID-19... (July 22, 2020)
Update From IAS 2020
Interactive Antiretroviral Cases From the Clinic(ians) and Panel Discussion
Multidimensional Challenge of COVID-19, Including COVId-19 and HIV
Preexposure Prophylaxis: Cases and Commom Questions
Why COVID-19 Will Not Mean the End of the STI Epidemic (and May Make It Worse)
COVID-19 Meets HIV: Focus on Health Disparities (June 30, 2020)
Common Preexposure Prophylaxis Questions: A Cased-Based Presentation
What's Known About the Intersection of COVID-19 and HIV Infection
The Current Status on Treatment and Vaccines